EFTR: eFFECTOR Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 0.85
Enterprise Value ($M) 0.85
Book Value ($M) 0.00
Book Value / Share 0.00
Price / Book n/a
NCAV ($M) 0.00
NCAV / Share 0.00
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) 0.00
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio n/a
Current Ratio n/a

Balance Sheet (mrq) ($M)
Current Assets 0.00
Assets 0.00
Liabilities 0.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
05-13 13D/A Carlyle Group Inc. 4.10 -96.00
02-14 13G/A Pfizer Inc 3.47 0.00
02-14 13G/A Sectoral Asset Management Inc 3.70 0.00
2024-02-09 13G/A Sr One Capital Management, Llc 0.00 -100.00
2024-02-05 13G/A Altitude Life Science Ventures Fund II, L.P. 4.40 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)

Similar Companies
DSKYF – Daiichi Sankyo Company, Limited EAPH – Parallel Industries Inc.
EAPIF – Euroapi S.A. EGRX – Eagle Pharmaceuticals, Inc.
ELOX – Eloxx Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io